Skip to main content
. 2014 Aug;6(8):408–412. doi: 10.4103/1947-2714.139296

Figure 2.

Figure 2

Effect of asafoetida at the doses of 50 and 100 mg/kg on SD, S4L, S5D, and ADD. *P < 0.05 indicates significant differences as compared to control. ADD after discharge duration, S5D stage 5 duration, SD seizure duration, S4L stage 4 latency